Skip to primary navigation
Skip to content
Skip to primary sidebar
Skip to footer

Selective AXL inhibitors

Header Right

Main navigation

About BerGenBio
Pipeline
Media Centre
Investors
Contact

Home / Investors / Stock Exchange Notices

Stock Exchange Notices

Primary Sidebar

Investors

News Subscription

Footer

Key Information

Pipeline
Investors
News
Presentations
Management Team

Useful Information

Privacy Policy
Terms of Use
Site Map

Get In Touch

BerGenBio ASA
Company registration number 992 219

Jonas Lies vei 91, 5009 Bergen, Norway

www.bergenbio.com

+ 47 559 61 159 (general) + 47 535 01 564 (urgent medical enquiries)

Copyright © 2017 BerGenBio ASA. All right reserved. Designed by Utopian Designs